Logo image of VUZI

VUZIX CORP (VUZI) Stock Fundamental Analysis

NASDAQ:VUZI - Nasdaq - US92921W3007 - Common Stock - Currency: USD

3.3111  -0.05 (-1.46%)

Fundamental Rating

3

VUZI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While VUZI has a great health rating, there are worries on its profitability. VUZI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year VUZI has reported negative net income.
In the past year VUZI has reported a negative cash flow from operations.
VUZI had negative earnings in each of the past 5 years.
In the past 5 years VUZI always reported negative operating cash flow.
VUZI Yearly Net Income VS EBIT VS OCF VS FCFVUZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of VUZI (-201.69%) is worse than 98.40% of its industry peers.
Looking at the Return On Equity, with a value of -219.59%, VUZI is doing worse than 92.00% of the companies in the same industry.
Industry RankSector Rank
ROA -201.69%
ROE -219.59%
ROIC N/A
ROA(3y)-91.88%
ROA(5y)-68.19%
ROE(3y)-98.06%
ROE(5y)-72.74%
ROIC(3y)N/A
ROIC(5y)N/A
VUZI Yearly ROA, ROE, ROICVUZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

VUZI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VUZI Yearly Profit, Operating, Gross MarginsVUZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VUZI has been increased compared to 1 year ago.
The number of shares outstanding for VUZI has been increased compared to 5 years ago.
VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VUZI Yearly Shares OutstandingVUZI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VUZI Yearly Total Debt VS Total AssetsVUZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

VUZI has an Altman-Z score of 34.89. This indicates that VUZI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 34.89, VUZI belongs to the top of the industry, outperforming 99.20% of the companies in the same industry.
VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 34.89
ROIC/WACCN/A
WACC9.29%
VUZI Yearly LT Debt VS Equity VS FCFVUZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 7.68 indicates that VUZI has no problem at all paying its short term obligations.
The Current ratio of VUZI (7.68) is better than 89.60% of its industry peers.
VUZI has a Quick Ratio of 6.21. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.21, VUZI belongs to the top of the industry, outperforming 87.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.68
Quick Ratio 6.21
VUZI Yearly Current Assets VS Current LiabilitesVUZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.00% over the past year.
VUZI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.37%.
VUZI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.91% yearly.
EPS 1Y (TTM)24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.25%
Revenue 1Y (TTM)-46.37%
Revenue growth 3Y-24.1%
Revenue growth 5Y-2.91%
Sales Q2Q%-21.11%

3.2 Future

VUZI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.24% yearly.
VUZI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.99% yearly.
EPS Next Y22.68%
EPS Next 2Y12.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.51%
Revenue Next 2Y44.99%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VUZI Yearly Revenue VS EstimatesVUZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
VUZI Yearly EPS VS EstimatesVUZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VUZI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VUZI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VUZI Price Earnings VS Forward Price EarningsVUZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VUZI Per share dataVUZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

VUZI's earnings are expected to grow with 12.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VUZI!.
Industry RankSector Rank
Dividend Yield N/A

VUZIX CORP

NASDAQ:VUZI (6/10/2025, 10:11:09 AM)

3.3111

-0.05 (-1.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-12 2025-08-12
Inst Owners16.58%
Inst Owner Change40.47%
Ins Owners6.95%
Ins Owner Change-0.14%
Market Cap252.44M
Analysts82.86
Price Target3.06 (-7.58%)
Short Float %27.12%
Short Ratio10.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.29%
Min EPS beat(2)-30.72%
Max EPS beat(2)10.13%
EPS beat(4)1
Avg EPS beat(4)-22.96%
Min EPS beat(4)-56.86%
Max EPS beat(4)10.13%
EPS beat(8)2
Avg EPS beat(8)-24.13%
EPS beat(12)3
Avg EPS beat(12)-17.61%
EPS beat(16)3
Avg EPS beat(16)-23.14%
Revenue beat(2)1
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-18.25%
Max Revenue beat(2)15.99%
Revenue beat(4)1
Avg Revenue beat(4)-22.81%
Min Revenue beat(4)-58.04%
Max Revenue beat(4)15.99%
Revenue beat(8)2
Avg Revenue beat(8)-26.32%
Revenue beat(12)3
Avg Revenue beat(12)-19.04%
Revenue beat(16)3
Avg Revenue beat(16)-20.67%
PT rev (1m)0%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)6%
Revenue NQ rev (3m)-34.86%
Revenue NY rev (1m)1.22%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 47.35
P/FCF N/A
P/OCF N/A
P/B 7.69
P/tB 8.73
EV/EBITDA N/A
EPS(TTM)-0.57
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.07
BVpS0.43
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -201.69%
ROE -219.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.88%
ROA(5y)-68.19%
ROE(3y)-98.06%
ROE(5y)-72.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.4%
Cap/Sales 45.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.68
Quick Ratio 6.21
Altman-Z 34.89
F-Score3
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)371.21%
Cap/Depr(5y)276.01%
Cap/Sales(3y)109.82%
Cap/Sales(5y)75.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.25%
EPS Next Y22.68%
EPS Next 2Y12.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-46.37%
Revenue growth 3Y-24.1%
Revenue growth 5Y-2.91%
Sales Q2Q%-21.11%
Revenue Next Year36.51%
Revenue Next 2Y44.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.32%
OCF growth 3YN/A
OCF growth 5YN/A